Precision Oncology Trials
Today, Precision Medicine is transforming Oncology, yielding new possibilities and potential treatments that improve patient outcomes. But this revolution comes with new complexities for conducting clinical trials:
Scarcity of eligible patients | Increasing clinical complexity | An abundance of disparate data
The Clinical Trial Dichotomy: too few, too much
Download the whitepaper to explore how Clinical Development Technology can help address two key challenges: too few patients who meet the eligibility criteria and too much disparate data on biomarkers and other parameters.
A Single Unified Platform addressing Oncology challenges
Watch the Webinar with Michel Becci, VP of Industry Strategy at Medidata and expert guest speaker Mark Maclean, Head of Clinical Data Management at NHMRC Clinical Trial Centre, University of Sydney as they discuss how a single unified platform can help you navigate the challenges and pitfalls of oncology trials.
Unlock the power of Unified Clinical Development
Our unified approach to clinical development in precision oncology trials supports you from the start of your clinical trial till the very end, on:
Planning | Site Selection | Patient Recruitment | Data Collection | Management, and Monitoring | Mid-trial adjustment | Post-trial Analysis to support Therapy Development
Learn how Medidata’s unified eClinical Platform can help your team from the start of your precision oncology trial to the very end, so you can conduct efficient, effective research that delivers targeted therapies and makes a real difference in the lives of patients.